Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

242 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of antibiotic stewardship on perioperative antimicrobial prophylaxis.
Murri R, de Belvis AG, Fantoni M, Tanzariello M, Parente P, Marventano S, Bucci S, Giovannenze F, Ricciardi W, Cauda R, Sganga G; collaborative SPES Group. Murri R, et al. Int J Qual Health Care. 2016 Sep;28(4):502-7. doi: 10.1093/intqhc/mzw055. Epub 2016 Jun 9. Int J Qual Health Care. 2016. PMID: 27283440
Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazanavir and Lamivudine for treatment Simplification, AtLaS pilot study).
Di Giambenedetto S, Fabbiani M, Colafigli M, Ciccarelli N, Farina S, Sidella L, D'Avino A, Mondi A, Cingolani A, Tamburrini E, Murri R, Navarra P, Cauda R, De Luca A. Di Giambenedetto S, et al. Among authors: murri r. J Antimicrob Chemother. 2013 Jun;68(6):1364-72. doi: 10.1093/jac/dkt007. Epub 2013 Jan 30. J Antimicrob Chemother. 2013. PMID: 23372058
Safety and efficacy of treatment switch to raltegravir plus tenofovir/emtricitabine or abacavir/lamivudine in patients with optimal virological control: 48-week results from a randomized pilot study (Raltegravir Switch for Toxicity or Adverse Events, RASTA Study).
Fabbiani M, Mondi A, Colafigli M, D'Ettorre G, Paoletti F, D'Avino A, Ciccarelli N, Sidella L, Murri R, Fortuna S, Vullo V, Cauda R, De Luca A, Di Giambenedetto S. Fabbiani M, et al. Among authors: murri r. Scand J Infect Dis. 2014 Jan;46(1):34-45. doi: 10.3109/00365548.2013.840920. Epub 2013 Oct 28. Scand J Infect Dis. 2014. PMID: 24161018 Clinical Trial.
Defining needs and goals of post-ICU care for trauma patients: preliminary study.
Bocci MG, Grieco DL, Lochi S, Minguell Del Lungo L, Pintaudi G, Caricato A, Murri R, Calabrese C, DE Belvis AG, Avolio M, Sandroni C, Antonelli M. Bocci MG, et al. Among authors: murri r. Minerva Anestesiol. 2016 Jan;82(1):22-9. Epub 2015 Apr 15. Minerva Anestesiol. 2016. PMID: 25875924 Free article.
242 results